Background: Since the advent of laparoscopic hysterectomy, several studies have described artefacts, such as vascular pseudoinvasion, constituting potential pitfalls in the histological evaluation of these specimens. The use of an intrauterine manipulator is often suggested as the factor creating these artefacts.
Objectives: To describe possible artefacts, such as vascular pseudoinvasion, myometrial clefts, and tumor cells in the lumen of the cervix, on the serosa, and in the tubal lumen, and to correlate them with clinical and pathological characteristics.
Material And Methods: This is a retrospective monocentric study of 60 patients having been treated for benign ( = 27, 45%) or malignant ( = 33, 55%) uterine pathologies.
Results: Vascular pseudoinvasion was found in 13 (22%) adenocarcinomas and in one (2%) benign uterine pathology. Clefts within the myometrium were observed in 16 (27%) uteri. Cells in the tubal lumen were observed in six (10%) hysterectomies. True vascular emboli were not correlated with the use of an intrauterine manipulator ( = 0.47) or the type of surgery ( = 0.21). Vascular pseudoinvasion was correlated with the presence of tumor cells in the lumen of the cervix ( = 0.013) and the presence of clefts in the myometrium ( < 0.001), but not with the other factors studied.
Conclusions: Overall, in our series, we did not observe any statistical association between the use of an intrauterine manipulator and the presence of true emboli or vascular pseudoinvasion during hysterectomy in women with malignant or benign uterine pathologies. Vascular pseudoinvasion was also associated with the presence of other artefacts.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11353742 | PMC |
http://dx.doi.org/10.3390/diagnostics14161833 | DOI Listing |
Diagnostics (Basel)
August 2024
Pathology Department, University Hospital of Saint-Etienne, 42270 Saint-Etienne, France.
Hum Pathol
April 2024
Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
Aims: Significance of peribiliary capillary plexus (PCP) in gallbladder neoplasms remains unclear. Aims are to characterize high-grade biliary intraepithelial neoplasm (BilIN), pyloric gland adenoma (PGA), and intracholecystic papillary neoplasm (ICPN), precursors of gallbladder carcinoma, and to differentiate invasive carcinoma from pseudo-invasive lesions in gallbladder walls, referring to PCP.
Materials And Methods: High-grade BilIN (38 cases), PGA (5 cases), and ICPN (25 cases) were examined using capillary immunostaining.
Arch Pathol Lab Med
September 2024
From the Department of Pathology and Laboratory Medicine (Abulaban, Yanchenko, Briski, Jorda, Kryvenko), Desai Sethi Urology Institute (Punnen, Jorda, Kryvenko), Department of Radiation Oncology (Kryvenko), and the Sylvester Comprehensive Cancer Center (Briski, Punnen, Jorda, Kryvenko), University of Miami Miller School of Medicine, Miami, Florida.
Context.—: Retraction artifact, paradoxic maturation/differentiation, desmoplasia, and complex irregular growth are morphologic criteria of invasion in urothelial carcinoma.
Objective.
Int J Surg Pathol
June 2024
Division of Pathology, Department of Diagnostic & Therapeutic Sciences, Meikai University School of Dentistry, Sakado, Saitama, Japan.
Zhonghua Bing Li Xue Za Zhi
January 2021
Department of Pathology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
To investigate the pathomorphological characteristics of colorectal adenoma with submucosal pseudoinvasion and to summarize the corresponding pseudoinvasion patterns. The clinicopathological data of 9 cases of colorectal adenoma were collected at 989 Hospital of PLA Joint Logistics Support Force (4 cases) and Beijing Chaoyang Hospital, Capital Medical University (5 cases), from 2016 to 2019. retrospectively, and the histomorphological characteristics and immunophenotypes were analyzed, and discussed in light of the relevant literature.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!